Cancer Family

Genitourinary System Neoplasm

Non-malignant3,846 active trials61 approved drugs306 evidence items

NCIt: C156482

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (852)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 852 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Cotinine enhances androgen receptor stability and promotes androgen-dependent proliferation in prostate cancer cells: An in vitro study.
Riri Hayashi, Yudai Kudo, Yuta Yoshino et al. · Arch Biochem Biophys · Nov 1, 2026 · PMID 42617929 · candidate dictionary pubmed
Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation.
Yaquan Cao, Yaxi Wu, Yunfei Li et al. · Bioorg Med Chem · Nov 1, 2026 · PMID 42612458 · candidate dictionary pubmed
[Corrigendum] Inactivation of von Hippel‑Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR‑210/VMP1 signaling pathway.
Ting Liu, Le Zhao, Wei Chen et al. · Int J Mol Med · Nov 1, 2026 · PMID 42725402 · candidate dictionary pubmed
[Expression of Concern] Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.
Xiaohui Zhao, Dayu Zhou, Yunen Liu et al. · Mol Med Rep · Nov 1, 2026 · PMID 42725400 · candidate dictionary pubmed
KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study.
Yuanyi Wang, Juan Yu, Wu Huang et al. · Oncol Lett · Nov 1, 2026 · PMID 42750893 · candidate dictionary pubmed
[Expression of Concern] RIP kinase‑mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin‑treated bladder cancer cells.
Yoon Hee Chung, Daejin Kim · Oncol Rep · Nov 1, 2026 · PMID 42757458 · candidate dictionary

pubmed

[Retracted] CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.

Long-Qiao Cao, Ya-Nan Wang, Ming Liang et al. · Mol Med Rep · Nov 1, 2026 · PMID 42788365 · candidate dictionary pubmed

Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer - a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100.

Xin Li, Yapeng Xing · Eur Urol Open Sci · Nov 1, 2026 · PMID 42787789 · candidate dictionary pubmed

Tumor‑immune spatiotemporal co‑evolution: A new paradigm for understanding and overcoming therapy resistance in metastatic castration‑resistant prostate cancer (Review).

Li Yan, Xiaoke Sun, Pengxiao Su · Int J Mol Med · Nov 1, 2026 · PMID 42788344 · candidate dictionary pubmed

Erratum: [Corrigendum] Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.

Mingqiu Hu, Jing Ning, Likai Mao et al. · Oncol Lett · Nov 1, 2026 · PMID 42761412 · candidate dictionary pubmed

Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle-Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report.

Yosuke Nakanishi, Yohei Kawashima, Masanao Shinohara et al. · IJU Case Rep · Nov 1, 2026 · PMID 42800938 · candidate dictionary pubmed

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis.

Clémentine Le Magnen, W Nathaniel Brennen, Álvaro Aytes et al. · Cancer Lett · Oct 28, 2026 · PMID 42617726 · candidate dictionary pubmed

Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models.

Jiaqi Wang, Yuanshi Jiao, Dawn Craig et al. · iScience · Oct 16, 2026 · PMID 42781478 · candidate dictionary pubmed

Selective anticancer activity of a multinuclear Cu(II) complex through apoptosis induction in ovarian cancer cells.

Li Gong, Mostafa Heidari Majd, Hamid Reza Ghaffari · Bioorg Chem · Oct 5, 2026 · PMID 42648236 · candidate dictionary pubmed

Novel Piperlongumine derivatives exert multimodal antitumor effects in prostate cancer via MAPK pathway activation, poly-mechanistic apoptosis induction, and DNMT3A-mediated DNA methylation reduction.

Yu Zhang, Xue Yang, Xuemei Qiu et al. · Bioorg Chem · Oct 5, 2026 · PMID 42612263 · candidate dictionary pubmed

Discovery of novel Quinazoline-chalcone hybrids as dual VEGFR-2/P-gp inhibitors to reverse cisplatin resistance in cervical Cancer.

Tong Yan, Mutewaer Muhebuli, Mourboul Ablise et al. · Bioorg Chem · Oct 5, 2026 · PMID 42623911 · candidate dictionary pubmed

Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.

Tanja C van Dijk, Marcel Smid, Debbie G J Robbrecht et al. · Eur J Cancer · Oct 5, 2026 · PMID 42623835 · candidate dictionary pubmed

Detected Huge Urinoma With 99mTc-PSMA Activity on Initial Prostate Cancer Staging.

Mohammad Ahmadi, Mohammad H Samadi, Amin Saber Tanha et al. · Clin Nucl Med · Oct 1, 2026 · PMID 42710082 · candidate dictionary pubmed

Green synthesis of silver nanoparticle using Hemidesmus indicus (L) R. Br. root extract and cytotoxicity assessment against ovarian cancer cell line (SKOV3).

Jayachandran Halka, Gayathiri Gunasangkaran, Kumaresan Kowsalya et al. · Cytotechnology · Oct 1, 2026 · PMID 42676590 · candidate dictionary pubmed

[Expression of Concern] Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.

Jing Guo, Li Chen, Ning Luo et al. · Oncol Rep · Oct 1, 2026 · PMID 42663282 · candidate dictionary pubmed

Characterization of B cell activation and spatial distribution in the tumor microenvironment of high-grade serous ovarian cancer.

Eleonora Capezzali, Martina Arcieri, Silvia Tonon et al. · Transl Oncol · Oct 1, 2026 · PMID 42660101 · candidate dictionary pubmed

LncRNA-driven alternative splicing landscapes associate with survival outcomes in ovarian cancer.

Yan Cao, Jian Zhao, Shan He et al. · Noncoding RNA Res · Oct 1, 2026 · PMID 42633203 · candidate dictionary pubmed

Integrative single-cell sequencing and machine learning analyses identify chronic inflammation and cancer-associated fibroblast subsets as drivers of adverse outcomes in ovarian cancer.

Mingqin Kuang, Changmei Shen, Chunping Yang et al. · Transl Oncol · Oct 1, 2026 · PMID 42632123 · candidate dictionary pubmed

NCAPD2 facilitates ovarian cancer progression via MYC-mediated unfolded protein response.

Guoying Cui, Hongqi Li, Yanqiu Wang et al. · Biochim Biophys Acta Mol Cell Res · Oct 1, 2026 · PMID 42586216 · candidate dictionary pubmed

Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

Ignace Vergote, David Cibula, Matthew Powell et al. · Lancet Oncol · Oct 1, 2026 · PMID 42705254 · candidate dictionary pubmed